abstract |
The present invention relates to compounds and compositions for the treatment and alleviation of inflammatory diseases. Specifically, the present invention includes, but is not limited to, compounds having tryptase inhibitory activity and intermediates thereof, pharmaceutical compositions comprising these compounds and other inflammatory diseases including, for example, asthma and senile macular degeneration. The present invention relates to a method for treating a subject suffering from a condition or disorder that can be alleviated by administration of a tryptase inhibitor. |